A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3

This publication has 17 references indexed in Scilit:

• Serum Levels of Insulin-like Growth Factor I, II, and Binding Protein 3, Transforming Growth Factor β-1, Soluble Fas Ligand and Superoxide Dismutase Activity in Stomach Cancer Cases and Their Controls in the JACC Study
  Journal of Epidemiology, 2005
• Insulin‐like growth factor (IGF)‐I and IGF‐binding protein 3 and the risk of premenopausal breast cancer: A meta‐analysis of literature
  International Journal of Cancer, 2004
• Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
  The Lancet, 2004
• Serum insulin‐like growth factor‐I, insulin‐like growth factor binding protein‐3, and the risk of pancreatic cancer death
  International Journal of Cancer, 2004
• Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men.
  American Journal of Epidemiology, 2003
• Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
  JNCI: Journal of the National Cancer Institute, 2000
• The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
  Endocrine Reviews, 2000
• Estimates of the worldwide incidence of 25 major cancers in 1990
  International Journal of Cancer, 1999
• Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
  JNCI: Journal of the National Cancer Institute, 1999
• Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery
  Journal of Korean Medical Science, 1997